global view constructed of white lines

Blog

Vintage vs modern surgery comparison
November 13, 2017

Craniopharyngioma: The Most Formidable of Intracranial Tumors

by Daniel F. Kelly

Although classified as benign, craniopharyngiomas pose a great challenge. Find out why Dr. Harvey Cushing, father of modern neurosurgery, called these pituitary tumors "the most formidable of intracranial tumors."

Cancer Survivor banner
November 7, 2017

Cancer and Survivorship

by Zara Jethani

The ever-expanding scope of medicine has radically transformed our lives. Now that we are living longer, how do we deal with diseases that come along with aging? Read about cancer survivorship strategies and how to thrive.

young woman looking thoughtful
November 1, 2017

Bridging the Survivorship Care Gap for Young Adult Survivors of Thyroid Cancer

by Zara Jethani

Although thyroid cancer is among the five most common carcinomas diagnosed in adolescents and young adults, Dr. Melanie Goldfarb's research shows a disconnect in their follow-up care. Read more about what can be done.

emergency room sign
October 15, 2017

What You Should Know About Stroke and Aneurysm Treatment

by Zara Jethani

Stroke and brain aneurysm are emergencies and a patient should be rushed to the ER for immediate treatment. Find out what you need to know about treatment.

SoCalBio Conference 2017 banner
October 9, 2017

Pacific Neuroscience Institute Research Paves a Way to the Future

by Karter White

Featured at the SoCal Biomedical Conference in September 2017, Drs. Chester Griffiths and Santosh Kesari highlight Pacific Neuroscience Institute's unique collaborative approach to research and patient care.

'The Scream' by Edvard Munch
October 3, 2017

October is Facial Pain Awareness Month

by Garni Barkhoudarian

An estimated 39 million people on the US have some degree of facial pain including TMJ dysfunction and notoriously painful Trigeminal Neuralgia. Read about these painful syndromes and available medical and surgical treatment options.

PNI Symposium 2017
Dr. Daniel Kelly with Dr. Neil Martin
Members of the PNI team with Brent Reynolds, PhD.
Mia Miller presenting at PNI Symposium 2017.
doctors presenting at a conference
group of peers posing together
Garni Barkhoudarian presenting at PNI Symposium 2017.
George P. Teitelbaum presenting at PNI Symposium 2017.
woman presenting at a conference
Sheldon Jordan, MD presenting at a conference
PNI lab team members posing together
Achal Singh Achrol presenting at PNI Symposium 2017.
group of peers posing together outside
Marisa Chang presenting at PNI Symposium 2017.
Doctor Glimp and Kelly outside at a conference
The PNI team posing with a keynote speaker
Jean-Philippe Langevin at a conference
Jason Tarpley at a conference
man presenting at a conference
Keynote speaker at a conference
September 29, 2017

Pacific Neuroscience Symposium 2017 Delivers The Goods

by Zara Jethani

Leading-edge continuing medical education for doctors ensures that patients receive the best possible neuro-care. Read about the advances in the neurosciences that translate to superior care in the clinic.

A Journey to New Frontiers banner
September 25, 2017

PATIENT STORY: Rusty’s Journey to New Frontiers in Glioblastoma Treatment

by Zara Jethani

Brain tumors sometimes make themselves known in baffling ways. With a trio of neurosurgeons and neuro-oncologists at his side, Rusty Doms takes a journey to new frontiers of glioblastoma treatment at the leading edge of medicine.

stroke victim receiving physical therapy
September 19, 2017

Reversing the Effects of a Stroke

by Zara Jethani

When a person suffers a stroke, millions of brain nerve cells die often resulting in motor disabilities such as paralysis and speech difficulties. What if researchers could challenge the brain to recover? That's what PNI researchers are doing for patients up to 7 1/2 years after their attack.

lab technician using a pipette
September 12, 2017

Santosh Kesari MD PhD, and Colleagues Publish New Glioblastoma Papers

by Guest Author

August 2017: The Lancet Oncology Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. August 2017: Nature Neuroscience A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. May 2017: International Journal of...

Last updated: January 6th, 2020